Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Taxus sales lift Boston Scientific in 3d quarter but stock takes slide Boston Scientific Corp. yesterday said third-quarter net income more than doubled, reflecting strong orders for the Natick company's drug-coated Taxus cardiac stents.
